A novel in vitro model for joint effects of alcohol and free fatty acids on hepatocellular steatosis and inflammation

2013 ◽  
Vol 51 (01) ◽  
Author(s):  
A Mahli ◽  
WE Thasler ◽  
M Müller ◽  
C Hellerbrand
2015 ◽  
Vol 76 ◽  
pp. 109-115 ◽  
Author(s):  
Ileana Hernández ◽  
Mayra Domínguez-Pérez ◽  
Leticia Bucio ◽  
Verónica Souza ◽  
Roxana U. Miranda ◽  
...  

2016 ◽  
Vol 90 ◽  
pp. 84-94 ◽  
Author(s):  
Giulia Vecchione ◽  
Elena Grasselli ◽  
Andrea D. Compalati ◽  
Milena Ragazzoni ◽  
Katia Cortese ◽  
...  

2015 ◽  
Vol 185 ◽  
pp. 268-276 ◽  
Author(s):  
Sara Costa ◽  
Cláudia Afonso ◽  
Carlos Cardoso ◽  
Irineu Batista ◽  
Nádia Chaveiro ◽  
...  

Biomolecules ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. 425 ◽  
Author(s):  
Marina Parra-Robert ◽  
Eudald Casals ◽  
Nuria Massana ◽  
Muling Zeng ◽  
Meritxell Perramón ◽  
...  

Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic accumulation of lipids. Antisteatotic effects of cerium oxide nanoparticles (CeO2NPs) have recently been shown in animal models of liver disease. However, it is unclear whether the activity of CeO2NPs is related solely to the decrease in oxidative stress or, in addition, they directly decrease liver fatty acid accumulation. To address this question, in this work, we used an in vitro model of hepatocellular steatosis, exposing HepG2 cells to oleic and palmitic acid. Cell uptake of CeO2NPs and their effect on oxidative stress and viability of hepatic cells cultured with H2O2 were also evaluated. Results show that CeO2NPs were uptaken by HepG2 cells and reduced oxidative stress and improved cell viability. Treatment with oleic and palmitic acid increased lipogenesis and the content of different fatty acids. CeO2NPs reduced palmitic and stearic acid and most fatty acids consisting of more than 18 carbon atoms. These effects were associated with significant changes in elongase and desaturase activity. In conclusion, CeO2NPs directly protected HepG2 cells from cell injury in oxidative stress conditions and reduced fatty acid content in steatotic conditions by inducing specific changes in fatty acid metabolism, thus showing potential in the treatment of NAFLD.


2011 ◽  
Vol 42 (3) ◽  
pp. 290-299 ◽  
Author(s):  
C. Navarro ◽  
I. González-Álvarez ◽  
M. González-Álvarez ◽  
M. Manku ◽  
V. Merino ◽  
...  

2009 ◽  
Vol 117 (4) ◽  
pp. 545-551 ◽  
Author(s):  
Brad L. Upham ◽  
Joon-Suk Park ◽  
Pavel Babica ◽  
Iva Sovadinova ◽  
Alisa M. Rummel ◽  
...  

Author(s):  
Madeleen Bosma ◽  
Dianne H. Dapito ◽  
Zoi Drosatos-Tampakaki ◽  
Ni Huiping-Son ◽  
Li-Shin Huang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document